Debkishore Mitra - Mar 1, 2022 Form 4 Insider Report for Lucira Health, Inc. (LHDXQ)

Role
Chief Technology Officer, Director
Signature
/s/ Dan George, Attorney-in-Fact for Debkishore Mitra, Ph.D.
Stock symbol
LHDXQ
Transactions as of
Mar 1, 2022
Transactions value $
-$4,509
Form type
4
Date filed
7/12/2022, 06:27 PM
Next filing
Sep 6, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LHDXQ Common Stock Sale -$4.17K -890 -0.23% $4.68* 383K Mar 1, 2022 Direct F1, F2
transaction LHDXQ Common Stock Sale -$344 -186 -0.05% $1.85* 382K Jun 1, 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the Restricted Stock Units granted on March 10, 2021 for 8,250 shares.
F2 Includes 1,470 shares and 2,552 shares acquired by the reporting person under the Issuer's 2021 Employee Stock Purchase Plan on August 20, 2021 and February 20, 2022, respectively.